Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
 
No Matching Results
Advanced search
or
Market: Market:
Menu

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Curis Announces Presentation at Cowen & Company 39th Annual Healthcare Conference PR Newswire - Mon Mar 4, 7:00AM CST
CMTX - Mon Mar 4, 7:00AM CST

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive...

CRIS : 1.43 (+4.38%)
Curis, Inc. to Present at the 2019 BIO CEO & Investor Conference PR Newswire - Mon Feb 4, 6:00AM CST
CMTX - Mon Feb 4, 6:00AM CST

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive...

CRIS : 1.43 (+4.38%)
Has Curis (CRIS) Outpaced Other Medical Stocks This Year? Zacks Equity Research - Zacks Investment Research - Tue Jan 29, 8:30AM CST
Zacks Equity Research - ZACKS - Tue Jan 29, 8:30AM CST

Is (CRIS) Outperforming Other Medical Stocks This Year?

CRIS : 1.43 (+4.38%)
Is Curis (CRIS) Outperforming Other Medical Stocks This Year? Zacks Equity Research - Zacks Investment Research - Thu Jan 10, 8:30AM CST
Zacks Equity Research - ZACKS - Thu Jan 10, 8:30AM CST

Is (CRIS) Outperforming Other Medical Stocks This Year?

CRIS : 1.43 (+4.38%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Jan 4, 3:00PM CST
CMTX - Fri Jan 4, 3:00PM CST

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on January 2, 2019, the independent Compensation...

CRIS : 1.43 (+4.38%)
Aduro BioTech (ADRO) Looks Good: Stock Adds 7.7% in Session Zacks Equity Research - Zacks Investment Research - Fri Jan 4, 7:39AM CST
Zacks Equity Research - ZACKS - Fri Jan 4, 7:39AM CST

Aduro BioTech (ADRO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

CRIS : 1.43 (+4.38%)
ADRO : 3.67 (-5.17%)
Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture -- Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire - Fri Nov 30, 6:45AM CST
CMTX - Fri Nov 30, 6:45AM CST

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dicerna Pharmaceuticals, Inc....

DRNA : 13.29 (-5.34%)
ADSK : 154.22 (-2.90%)
CRIS : 1.43 (+4.38%)
EGRX : 47.15 (-6.85%)
SLF : 37.45 (-2.50%)
ACN : 165.24 (-1.78%)
Curis to Present at the 60th Annual Meeting of the American Society of Hematology PR Newswire - Tue Nov 20, 9:45AM CST
CMTX - Tue Nov 20, 9:45AM CST

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced three upcoming poster presentations...

CRIS : 1.43 (+4.38%)
Curis: 1Q Earnings Snapshot APAI - Thu May 3, 7:58AM CDT
APAI - Thu May 3, 7:58AM CDT

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Thursday reported a loss of $10.7 million in its first quarter.

CRIS : 1.43 (+4.38%)
Curis Reports First Quarter 2018 Financial Results PR Newswire - Thu May 3, 6:00AM CDT
CMTX - Thu May 3, 6:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today reported its financial results...

CRIS : 1.43 (+4.38%)
Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018 PR Newswire - Thu Apr 26, 6:00AM CDT
CMTX - Thu Apr 26, 6:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company...

CRIS : 1.43 (+4.38%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Apr 6, 6:00AM CDT
CMTX - Fri Apr 6, 6:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today announced that...

CRIS : 1.43 (+4.38%)
Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals -- Discovering Underlying Factors of Influence GlobeNewswire - Tue Apr 3, 7:01AM CDT
CMTX - Tue Apr 3, 7:01AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atrion Corporation (NASDAQ:ATRI),...

FF : 13.19 (-6.25%)
UTMD : 80.49 (-3.98%)
OPNT : 13.15 (-6.21%)
ATRI : 841.70 (-0.72%)
CRIS : 1.43 (+4.38%)
ICD : 2.74 (-6.16%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
Fri Mar 1, 1:48PM CST
TMQ -0.16
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot